Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTPN1 | P18031 | 1/20 | 0.33 |
| ▸ | ACHE | P22303 | 1/20 | 0.31 |
| ▸ | GPR3 | P46089 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL64312 | 0.81 | PTPN1 (0.33) | PTPN1ACHE | |
| SCHEMBL8720545 | 0.73 | — | — | |
| SCHEMBL64465 | 0.73 | CES2 (0.31) | — | |
| SCHEMBL6941430 | 0.64 | — | — | |
| Trifluoromethanesulfonic Acid SCHEMBL63721 | 0.62 | GPR3 (0.43) | PTPN1ACHEGPR3 | |
| Trifluoromethanesulfonic Acid SCHEMBL9686740 | 0.62 | KCNH2 (0.44) | ACHEGPR3 | |
| Trifluoromethanesulfonic Acid SCHEMBL9066395 | 0.58 | KCNH2 (0.55) | ACHEGPR3 | |
| SCHEMBL14964902 | 0.58 | TSHR (0.32) | ACHE | |
| SCHEMBL14964904 | 0.58 | TSHR (0.32) | ACHE | |
| SCHEMBL5082293 | 0.57 | CA1 (0.59) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1857452-A1 | CONDENSATION COMPOUND BETWEEN FLUORINATED CYCLOPENTANE RING AND AROMATIC RING, AND PROCESS FOR PRODUCING THE SAME | OSAKA UNIVERSITY (JP) | 2007-11-21 | — | — | EP | claimed |
| US-8207184-B2 | Condensation compound between fluorinated cyclopentane ring and aromatic ring, and process for producing the same | SUMITOMO CHEMICAL CO., LTD. (JP) | 2012-06-26 | — | — | US | disclosed |
| US-8129400-B2 | Condensation compound between fluorinated cyclopentane ring and aromatic ring, and process for producing the same | SUMITOMO CHEMICAL CO., LTD. (JP) | 2012-03-06 | — | — | US | disclosed |
| US-8114956-B2 | Polymer having unit obtained by condensation of difluorocyclopentanedione ring and aromatic ring, organic thin film using the same, and organic thin film device | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2012-02-14 | — | — | US | disclosed |
| US-20110282073-A1 | CONDENSATION COMPOUND BETWEEN FLUORINATED CYCLOPENTANE RING AND AROMATIC RING, AND PROCESS FOR PRODUCING THE SAME | SUMITOMO CHEMICAL CO., LTD. (JP) | 2011-11-17 | — | — | US | disclosed |
| US-20110213162-A1 | CONDENSATION COMPOUND BETWEEN FLUORINATED CYCLOPENTANE RING AND AROMATIC RING, AND PROCESS FOR PRODUCING THE SAME | SUMITOMO CHEMICAL CO., LTD. (JP) | 2011-09-01 | — | — | US | disclosed |
| US-8008336-B2 | Forming electronic material, semiconductors | SUMITOMO CHEMICAL CO., LTD. (JP) | 2011-08-30 | — | — | US | disclosed |
| US-7932347-B2 | Polymer comprising unit comprising fluorocyclopentane ring fused with aromatic ring and organic thin film and organic thin film element both comprising the same | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2011-04-26 | — | — | US | disclosed |
| US-20100084640-A1 | POLYMER HAVING UNIT OBTAINED BY CONDENSATION OF DIFLUOROCYCLOPENTANEDIONE RING AND AROMATIC RING, ORGANIC THIN FILM USING THE SAME, AND ORGANIC THIN FILM DEVICE | SUMITOMO CHEMICAL COMPANY LIMITED (JP) | 2010-04-08 | — | — | US | disclosed |
| EP-2123690-A1 | POLYMER HAVING UNIT OBTAINED BY CONDENSATION OF DIFLUOROCYCLOPENTANEDIONE RING AND AROMATIC RING, ORGANIC THIN FILM USING THE SAME, AND ORGANIC THIN FILM DEVICE | Sumitomo Chemical Company, Limited (JP) | 2009-11-25 | — | — | EP | disclosed |
| US-6689766-B2 | ALSO FOR TREATING MALIGNANT TUMORS, RHEUMATOID ARTHRITIS, OSTEOPOROSIS, DIABETES MELLITUS, HYPERTENSION, ALOPECIA, ACNE, PSORIASIS, DERMATITIS, HYPERCALCEMIA, HYPOPARATHYROIDISM AND METABOLIC DISORDER OF CARTILAGE. | TEIJIN LIMITED (JP) | 2004-02-10 | — | — | US | disclosed |
| US-6548489-B2 | Also for treating malignant tumors, rheumatoid arthritis, osteoporosis, diabetes mellitus, hypertension, alopecia, acne, psoriasis, dermatitis, hypercalcemia, hypoparathyroidism and metabolic disorder of cartilage. | TEIJIN LIMITED (JP) | 2003-04-15 | — | — | US | disclosed |
| US-6531460-B1 | Vitamin D3 derivatives | TEIJIN LIMITED (JP) | 2003-03-11 | — | — | US | disclosed |
| US-20020132799-A1 | Vitamin D3 dervative and treating agent for inflammatory respiratory disease using same | TEIJIN LIMITED | 2002-09-19 | — | — | US | disclosed |
| US-20020103173-A1 | Vitamin D3 derivative and treating agent for inflammatory respiratory disease using same | TEIJIN LIMITED | 2002-08-01 | — | — | US | disclosed |
| US-20020099039-A1 | Vitamin D3 derivative and treating agent for inflammatory respiratory disease using same | TEIJIN LIMITED | 2002-07-25 | — | — | US | disclosed |
| US-20020091109-A1 | Vitamin D3 derivative and treating agent for inflammatory respiratory disease using same | TEIJIN LIMITED | 2002-07-11 | — | — | US | disclosed |
| EP-1123921-A1 | VITAMIN D 3? DERIVATIVES AND REMEDIES FOR INFLAMMATORY RESPIRATORY DISEASES CONTAINING THE SAME | TEIJIN LIMITED (JP) | 2001-08-16 | — | — | EP | disclosed |
| US-6174628-B1 | ELECTROLYTE HAS HIGH POLARITY, HIGH RESISTANCE TO OXIDATION AND FLAME RETARDANCE, AND THUS POSSESSES EXCELLENT CHARACTERISTICS AS THE ELECTROLYTE FOR ELECTRIC ENERGY GENERATORS | DAIKIN INDUSTRIES, LTD. (JP) | 2001-01-16 | — | — | US | disclosed |
| EP-0948073-A1 | ELECTROLYTIC SOLUTION AND DEVICE FOR GENERATING ELECTRIC ENERGY THEREWITH | Daikin Industries, Ltd. (JP) | 1999-10-06 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020103173-A1 | Vitamin D3 derivative and treating agent for inflammatory respiratory disease using same | CYP24A1, VDR, CYP2R1 | PTPN1 3342/4885ACHE 4600/4885GPR3 378/4885 |
| US-20020132799-A1 | Vitamin D3 dervative and treating agent for inflammatory respiratory disease using same | CYP24A1, VDR, CYP2R1 | PTPN1 2933/4885ACHE 4665/4885GPR3 553/4885 |
| US-20110213162-A1 | CONDENSATION COMPOUND BETWEEN FLUORINATED CYCLOPENTANE RING AND AROMATIC RING, AND PROCESS FOR PRODUCING THE SAME | RCC1, AFF4, TPR | PTPN1 3622/4885ACHE 3434/4885GPR3 4207/4885 |
| US-20110282073-A1 | CONDENSATION COMPOUND BETWEEN FLUORINATED CYCLOPENTANE RING AND AROMATIC RING, AND PROCESS FOR PRODUCING THE SAME | RCC1, AFF4, TPR | PTPN1 3622/4885ACHE 3434/4885GPR3 4207/4885 |
| US-20020099039-A1 | Vitamin D3 derivative and treating agent for inflammatory respiratory disease using same | CYP24A1, VDR, CYP2R1 | PTPN1 3342/4885ACHE 4600/4885GPR3 378/4885 |
| US-20020091109-A1 | Vitamin D3 derivative and treating agent for inflammatory respiratory disease using same | CYP24A1, VDR, CYP2R1 | PTPN1 3342/4885ACHE 4600/4885GPR3 378/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.